Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis

被引：0
|
作者：
A Matakidou
R el Galta
M F Rudd
E L Webb
H Bridle
T Eisen
R S Houlston
机构：
[1] Section of Cancer Genetics,Department of Oncology
[2] Institute of Cancer Research,undefined
[3] University of Cambridge,undefined
来源：
British Journal of Cancer | 2007年 / 96卷
关键词：
lung cancer; FGFR4; Gly388Arg polymorphism; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Gly388Arg polymorphism in the fibroblast growth factor receptor 4 (FGFR4) gene has been reported to influence prognosis in a wide variety of cancer types. To determine whether Gly388Arg is a marker for lung cancer prognosis, we genotyped 619 lung cancer patients with incident disease and examined the relationship between genotype and overall survival. While we employed a comprehensive set of statistical tests, including those sensitive to the detection of differences in early survival, our data provide little evidence to support the tenet that the FGFR4 Gly388Arg polymorphism is a clinically useful marker for lung cancer prognosis.
引用
收藏
页码：1904 / 1907
页数：3
相关论文
共 50 条
  • [31] Association of the fibroblast growth factor receptor-4 (FGFR4) Gly388Arg polymorphism with clinical and pathological response to primary systemic therapy (PST) for early breast cancer (EBC)
    Marme, F.
    Sohn, C.
    Burwinkel, B.
    Sinn, P.
    Hahn, M.
    Lichter, P.
    Benner, A.
    Schneeweiss, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet
    Lutz, Stefan Z.
    Hennige, Anita M.
    Peter, Andreas
    Kovarova, Marketa
    Totsikas, Charisis
    Machann, Jurgen
    Kroeber, Stefan M.
    Sperl, Bianca
    Schleicher, Erwin
    Schick, Fritz
    Heni, Martin
    Ullrich, Axel
    Haering, Hans-Ulrich
    Stefan, Norbert
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 2041 - 2053
  • [33] FGFR4 Arg388 polymorphism is a poor prognostic factor for resected stage III colon cancer
    Cho, Sang-Hee
    Shin, Min-Ho
    Kweon, Sun-Seog
    Kim, Hee-Nam
    Shim, Hyun-Jeong
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Chung, Lk-Joo
    CANCER RESEARCH, 2015, 75
  • [34] FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma
    Akdeniz Odemis, Demet
    Tuncer, Seref Bugra
    Adamnejad Ghafour, Arash
    Jabbarli, Khariga
    Gider, Yasemin
    Celik, Betul
    Kuru Turkcan, Gozde
    Sukruoglu Erdogan, Ozge
    Kilic Erciyas, Seda
    Avsar, Mukaddes
    Kebudi, Rejin
    Buyukkapu Bay, Sema
    Tuncer, Samuray
    Yazici, Hulya
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [35] RETRACTED: Association between Fibroblast Growth Factor Receptor 4 Gly388Arg Polymorphism and Ischaemic Stroke (Retracted Article)
    Zhang, H. F.
    Zhao, K. J.
    Yang, P. F.
    Fang, Y. B.
    Zhang, Y. H.
    Liu, J. M.
    Huang, Q. H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (05) : 1708 - 1714
  • [36] Analyis of FGFR4 GIy388Arg polymorphism as a prognostic factor in resected hepatic metastases of colorectal cancer
    Baixeras, Nuria
    Padulles, Laura
    Mollevi, David G.
    Serrano, Teresa
    Condom, Enric
    Ramos, Emilio
    Torras, Jaume
    Salazard, Ramon
    Capella, Gabriel
    Villanueva, Alberto
    VIRCHOWS ARCHIV, 2008, 452 : S214 - S214
  • [37] Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas
    Wimmer, Eva
    Ihrler, Stephan
    Gires, Olivier
    Streit, Sylvia
    Issing, Wolfgang
    Bergmann, Christoph
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (03): : 136 - 148
  • [38] Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population
    Chen, Q.
    Li, W. J.
    Wan, Y. Y.
    Yu, C. D.
    Li, W. G.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (01) : 548 - 555
  • [39] Cancer progression and tumor cell motility are associated with the FGFR4 Arg388 allele
    Bange, J
    Prechtl, D
    Cheburkin, Y
    Specht, K
    Harbeck, N
    Schmitt, M
    Knyazeva, T
    Müller, S
    Gärtner, S
    Sures, I
    Wang, HY
    Imyanitov, E
    Häring, HU
    Knayzev, P
    Iacobelli, S
    Höfler, H
    Ullrich, A
    CANCER RESEARCH, 2002, 62 (03) : 840 - 847
  • [40] Fibroblast growth factor receptor 4 Gly388Arg polymorphism is not associated with pre-eclampsia in Turkish women
    Gunes, Emine Gulsen
    Pinarbasi, Ergun
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (12) : 1824 - 1827
12345